Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWMGet Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 900 shares, a growth of 800.0% from the January 31st total of 100 shares. Based on an average daily trading volume, of 2,400 shares, the short-interest ratio is presently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

HROWM traded down $0.08 during trading on Thursday, reaching $26.61. 1,538 shares of the company were exchanged, compared to its average volume of 2,915. The firm has a 50 day moving average of $26.48 and a 200 day moving average of $26.42. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52 week low of $25.30 and a 52 week high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th were given a $0.7422 dividend. The ex-dividend date was Wednesday, January 15th. This represents a $2.97 annualized dividend and a yield of 11.16%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

(Get Free Report)

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.

Further Reading

Receive News & Ratings for Harrow Health Inc. 11.875% Senior Notes due 2027 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harrow Health Inc. 11.875% Senior Notes due 2027 and related companies with MarketBeat.com's FREE daily email newsletter.